What Allstate’s latest earnings and buyback activity mean for investors

Allstate (ALL) just released second quarter 2026 results that show higher revenue, higher net income, and stronger earnings per share, along with ongoing share repurchases that reduced the share count and returned more cash to shareholders.

Allstate’s latest quarterly results and buybacks come after a strong run in the stock, with a 90 day share price return of 24.88% and year to date share price return of 31%. Over longer horizons the total shareholder return of 31.71% over 1 year and very large 3 year and 5 year total shareholder returns indicate that momentum has remained strong rather than fading.

If Allstate’s performance has you thinking about what else might be gaining investor attention, this is a good moment to broaden your search and check out 19 top founder-led companies

After a sharp move in Allstate’s share price and a market valuation that now sits almost on top of analyst targets, the bigger question is whether the large implied discount to intrinsic value reflects real risks or an opportunity.

Most Popular Narrative: 4.8% Overvalued

Allstate’s last close at $267 sits modestly above the most followed fair value estimate of $254.68, which is built on detailed earnings and margin forecasts using a 7.11% discount rate.

The rollout of Allstate's new digitally enabled, "Affordable, Simple, Connected" auto and homeowner products across multiple states, coupled with sophisticated pricing and expanded distribution, is expected to drive profitable policy growth and improve top-line revenue as traditional and direct-to-consumer channels scale.

Want to understand why this narrative still lands slightly below today’s price? It rests on slower profit growth, thinner long term margins, and a future earnings multiple that asks investors to accept a very different profitability profile than today.

Result: Fair Value of $254.68 (OVERVALUED)

However, the Allstate narrative can be knocked off course if catastrophe losses stay elevated, or if regulatory pushback slows needed rate increases in key states.

Another view on Allstate’s valuation

The analyst narrative tags Allstate as 4.8% overvalued relative to a $254.68 fair value, yet the market is pricing the stock at only 5.1x earnings while the estimated fair ratio is 7.3x and the US Insurance industry and peer averages sit around 11.6x and 10.5x. That gap suggests the multiple-based view points to a very different balance of risk and potential opportunity. Which lens do you trust more when the story and the numbers pull in opposite directions?

Next Steps

If the mix of optimism and concern around Allstate feels hard to balance, do not wait to check the data and decide for yourself. To weigh both sides of the story in one place, start with the 4 key rewards and 1 important warning sign

Looking for more investment ideas beyond Allstate?

If Allstate has sharpened your focus, do not stop there. Broaden your watchlist now so you are not the one hearing about the next opportunity after it moves.

• Target steady compounding potential by checking companies that combine quality with attractive entry points through the 52 high quality undervalued stocks
• Strengthen your income stream by reviewing stocks that pay meaningful yields and aim for staying power using the 8 dividend fortresses
• Prioritise resilience by scanning companies with robust finances and fundamentals through the solid balance sheet and fundamentals stocks screener (48 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.